Tumors use many strategies to evade the immune system. A new study adds a new trick to the list—inhibiting the migration of dendritic cells from tumors toward lymph nodes (pages 98–105).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Katie Vicari
References
Villablanca, E.J. et al. Nat. Med. 16, 98–105 (2010).
van Mierlo, G.J.D. et al. J. Immunol. 173, 6753–6759 (2004).
Melief, C.J.M. Immunity 29, 372–383 (2008).
Sica, A. & Bronte, V. J. Clin. Invest. 117, 1155–1166 (2007).
Kortylewski, M. & Yu, H. Curr. Opin. Immunol. 20, 228–233 (2008).
Steinman, R.M. & Banchereau, J. Nature 449, 419–426 (2007).
Bensinger, S.J. & Tontonoz, P. Nature 454, 470–477 (2008).
Bensinger, S.J. et al. Cell 134, 97–111 (2008).
A-Gonzalez, N. Immunity 31, 245–258 (2009).
Nowak, A.K. et al. Adv. Drug Deliv. Rev. 58, 975–990 (2006).
Green, D.R. et al. Nat. Rev. Immunol. 9, 353–363 (2009).
Broomfield, S.A. et al. J. Immunol. 182, 5217–5224 (2009).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Melief, C. Migration or evasion. Nat Med 16, 35–36 (2010). https://doi.org/10.1038/nm0110-35
Issue Date:
DOI: https://doi.org/10.1038/nm0110-35
